Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 1.0B | 1.0B | 809M | 1.0B |
| Cost of revenue | 870M | 877M | 708M | 873M |
| Gross profit | 133M | 148M | 101M | 139M |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 33M | 40M | 35M | 42M |
| Other operating expenses | 7M | 10M | 2M | -2M |
| Operating income | 93M | 98M | 64M | 99M |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 82M | 91M | 55M | 86M |
| Tax provision | 17M | 18M | 12M | 18M |
| Net income | 65M | 73M | 43M | 68M |
| Basic EPS | 2.3 | 2.6 | 1.5 | 2.3 |
| Diluted EPS | 2.3 | 2.6 | 1.5 | 2.3 |
| Basic average shares | 28.5M | 28.5M | 28.8M | 29.0M |
| Diluted average shares | 28.5M | 28.5M | 28.8M | 29.0M |
| EBITDA | 125M | 129M | 94M | 129M |
| Net income from continuing op. | 82M | 91M | 55M | 86M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | 0 | 0 | 0 | 0 |